FDA labeling based on patient-reported outcome diaries

被引:0
|
作者
Gnanasakthy, Ari [1 ]
Carty, Michelle [1 ]
机构
[1] QualityMetric, Johnston, RI USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:S16 / S16
页数:1
相关论文
共 50 条
  • [1] FDA PATIENT-REPORTED OUTCOME LABELING OF NOVEL THERAPIES (2011-2015)
    Gnanasakthy, A.
    Mordin, M.
    Haydysch, E.
    DeMuro, C.
    VALUE IN HEALTH, 2016, 19 (03) : A285 - A286
  • [2] Recent trends in the inclusion of patient-reported outcome (PRO) data in approved drugs labeling by FDA and EMEA
    Caron, M.
    Emery, M. P.
    Marquis, P.
    Piault, E.
    VALUE IN HEALTH, 2008, 11 (03) : A54 - A54
  • [3] UPDATE OF TRENDS IN THE INCLUSION OF PATIENT-REPORTED OUTCOME (PRO) DATA IN APPROVED DRUGS LABELING BY FDA AND EMEA
    Caron, M.
    Emery, M. P.
    Marquis, P.
    Piault, E.
    VALUE IN HEALTH, 2008, 11 (06) : A574 - A574
  • [4] Patient-reported outcomes to support medical product labeling claims: FDA perspective
    Patrick, Donald L.
    Burke, Laurie B.
    Powers, John H.
    Scott, Jane A.
    Rock, Edwin P.
    Dawisha, Sahar
    O'Neill, Robert
    Kennedy, Dianne L.
    VALUE IN HEALTH, 2007, 10 : S125 - S137
  • [5] New Patient-Reported Outcome Measures for Early Systemic Sclerosis Using the FDA Guidance on Patient Reported Outcome Measures
    Khanna, Dinesh
    Greene, George
    Perschon, Chelsea
    Lescoat, Alain
    Jaeger, Emilie
    Murphy, Susan
    Cella, David
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3223 - 3225
  • [6] Patient-reported outcome
    Alten, R.
    Schneider, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (08): : 696 - 697
  • [7] Responder Definition of a Patient-Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance
    Lien, Han-Chung
    Wang, Chen-Chi
    Lee, Shou-Wu
    Hsu, Jeng-Yuan
    Yeh, Hong-Zen
    Ko, Chung-Wang
    Chang, Chi-Sen
    Liang, Wen-Miin
    VALUE IN HEALTH, 2015, 18 (04) : 396 - 403
  • [8] Interpreting patient-reported outcome results: US FDA guidance and emerging methods
    McLeod, Lori D.
    Coon, Cheryl D.
    Martin, Susan A.
    Fehnel, Sheri E.
    Hays, Ron D.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (02) : 163 - 169
  • [9] US FDA patient-reported outcome guidance: great expectations and unintended consequences
    Fehnel, Sheri
    DeMuro, Carla
    McLeod, Lori
    Coon, Cheryl
    Gnanasakthy, Ari
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (04) : 441 - 446
  • [10] Access to patient-reported outcome (PRO) instruments and their translations in the light of FDA recommendations
    Anfray, C.
    Emery, M. P.
    VALUE IN HEALTH, 2008, 11 (03) : A180 - A180